Binding to nucleosomal DNA is critical for 'pioneer' transcription factors such as the winged-helix transcription factors Foxa1 and Foxa2 to regulate chromatin structure and gene activation. Here we report the genome-wide map of nucleosome positions in the mouse liver, with emphasis on transcriptional start sites, CpG islands, Foxa2 binding sites and their correlation with gene expression. Despite the heterogeneity of liver tissue, we could clearly discern the nucleosome pattern of the predominant liver cell, the hepatocyte. By analyzing nucleosome occupancy and the distributions of heterochromatin protein 1 (Hp1), CBP (also known as Crebbp) and p300 (Ep300) in Foxa1-and Foxa2-deficient livers, we find that the maintenance of nucleosome position and chromatin structure surrounding Foxa2 binding sites is independent of Foxa1 and Foxa2.
r e s o u r c e Current ultra-high-throughput sequencing technologies allow for high-resolution mapping of nucleosome positions throughout the genome 1 . Thus far, high-resolution maps of nucleosomes have been obtained for Caenorhabditis elegans, yeast and human cell lines [1] [2] [3] but not for other mammalian tissues. Most transcription factors prefer to bind to double-stranded DNA at nucleosome-free regions 1, 4 ; however, previous in vitro studies have also shown that several pioneer transcription factors, such as the Foxa proteins, the glucocorticoid receptor (Nr3c1) and Sp1, are able to bind to nucleosomal DNA [5] [6] [7] . Gene ablation studies have shown that Foxa1 and Foxa2 redundantly regulate liver development and metabolism, whereas the role of Foxa3 in the liver is limited [8] [9] [10] [11] . Foxa1 and Foxa2 have been suggested to act as pioneer factors in liver development 12 . This model is supported by in vitro studies showing that Foxa proteins decompact chromatin and reposition nucleosomes by binding to nucleosome-occupied DNA at the albumin gene (also known as Alb1 or Alb) enhancer site 5 . However, the role of the Foxa factors with respect to nucleosome positioning in vivo remains to be determined.
RESULTS

Mapping nucleosomes with MNase-Seq or H3K4me1 ChIP-Seq
Presently, only very limited information is available regarding nucleosome positions in the mammalian liver. Recently, some researchers used limited reads from ChIP-Seq for H3K4me1 as a surrogate to approximate nucleosome positions in the mouse liver and concluded that H3K4me1 occupancy was sufficient to define most of the Foxa2 binding sites in the genome by forming 'bimodal' nucleosomal boundaries surrounding Foxa2 binding sites 13 . This shortcut, although convenient and cost-saving, suffers from several limitations. First, by definition, only histones with this specific modification, in other words, only H3K3me1, were 'counted'; thus, the vast majority of nucleosomes were missed. Second, ChIP-Seq for H3K4me1 is limited in resolution owing to the sonication process, so the precise boundary of the nucleosome could not be determined. This issue is illustrated in Figure 1 , in which we compare nucleosome positions at the Alb1 locus obtained by microccocal nuclease digestion (this study, see below) to the nucleosome occupancy estimated by others 13 . Figure 1a demonstrates how, when only on H3K4me1 ChIP-Seq data were used, many adjacent nucleosomes were fused together into one nucleosomal area, whereas other nucleosomes were completely missed 13 . In addition, the well-studied Foxa2 binding site in the Alb1 enhancer had been reported as bimodal, or flanked by nucleosomes, by means of ChIP-Seq for H3K4me1 (ref. 13 ), but we could not reproduce this finding, as our analysis clearly showed that there is a nucleosome positioned exactly over the Foxa2 binding site ( Fig. 1b) . Therefore, the determination of nucleosome occupancy by microccocal nuclease digestion followed by ultra-high-throughput sequencing is a more powerful method to resolve nucleosome position than relying solely on ChIP-Seq for H3K4me1.
Nucleosome dynamics in the mouse liver
To investigate nucleosome occupancy in the mouse liver genomewide, we isolated native chromatin and directly digested it with microccocal nuclease (MNase), which cannot digest DNA wrapped around the histone octamer ( Supplementary Fig. 1 ). Using ultrahigh-throughput sequencing, we obtained ~124 million uniquely aligned sequence reads, resulting in a genome-wide map of nucleosome occupancy. We found it striking that despite the fact that the liver is not a homogenous tissue, the nucleosome profile showed a distinct pattern that reflected the status of chromatin in the predominant cell type, the hepatocyte. The nucleosome occupancy at the Alb1 locus is shown as an example in Figure 2a-c. Three major features of nucleosome occupancy were found at the Alb1 locus and other hepatocyte-expressed genes: first, nucleosome positions were similar in the majority of hepatocytes; second, nucleosomes were not equally spaced even in nucleosome-rich regions; third, a wide nucleosome-free region was found surrounding transcriptional start sites. r e s o u r c e Genome-wide mapping of nucleosome positions provides the opportunity to study the link between nucleosome position and well-known genomic landmarks such as transcriptional start sites and CpG islands, the latter predominantly found near housekeeping genes 14, 15 . Our analysis of nucleosome distribution surrounding transcriptional start sites revealed that ~70% of them were nucleosome free, with the nucleosome-free regions spanning approximately one to two nucleosome widths ( Fig. 2d) . Similar to what has been found in cultured cells 1, 16 , transcriptional start sites of active genes showed lower nucleosome occupancy than those of silent genes (Fig. 2d) . This is exemplified by the nucleosome occupancy of the Alb1 locus, which is active in the liver, and of the insulin 1 (Ins1) locus, which is not ( Fig. 2c, Supplementary Fig. 2) ; thus, the initiation of gene transcription in the liver depends, at least in part, on displacement of nucleosomes from transcriptional start sites. As expected, CpG island-associated genes showed lower nucleosome occupancy surrounding transcriptional start sites than genes lacking CpG islands ( Fig. 2e, Supplementary Fig. 3 ). CpG islands themselves were nucleosome depleted even at intergenic locations ( Fig. 2f, Supplementary Fig. 3 ). The genome-wide nucleosome coverage was about 60% ( Fig. 2d-f ). We also investigated the size of the nucleosome-free regions in the whole genome and near transcriptional start sites. The majority of nucleosome-free regions in the whole genome were less than 100 base pairs (bp) in size, whereas 30 Figure 1 Mapping of nucleosome positions by micrococcal nuclease is more informative than the use of H3K4me1 ChIP-Seq data. (a) Nucleosome positions mapped by micrococcal nuclease digestion followed by ultra-high-throughput sequencing (blue) and H3K4me1 ChIP-Seq data from mouse liver based on a cutoff of more than six reads per position (orange) 13 . Nucleosome position estimation based on H3K4me1 ChIP-Seq data is unable to resolve closely spaced nucleosomes and also misses multiple nucleosomes detected by mapping of nucleosomes with micrococcal nuclease. Near the 5′ end of the Alb1 gene, H3K4me1 ChIP-Seq data miss two important nucleosomes just downstream of the transcriptional start site, most likely because at this position H3 was methylated further to the me2 and me3 forms. (b) The well-known Foxa binding site in the albumin enhancer was previously thought to be bimodal-in other words, nucleosome free 13 ; however, our data clearly show that the site is occupied by a nucleosome. Blue arrows indicate corresponding regions in upper and lower panels. All, all annotated genes from the UCSC genome database; Active, 1,000 genes with the highest expression in the liver; Silent, 1,000 genes with no expression in the liver. (e) Nucleosome distribution surrounding TSS of genes associated with (CpG + ) and without (CpG − ) CpG islands. (f) Nucleosome distribution surrounding CpG islands. Either all CpG islands or those located more than 5 kb distant from the nearest gene (intergenic) were analyzed. (g) Sizes of nucleosome-free regions at Foxa2 binding sites, surrounding transcriptional start sites, or in the whole genome (All). r e s o u r c e the nucleosome-free regions surrounding transcriptional start sites had a wider range ( Fig. 2g) , indicating uneven spacing between adjacent nucleosomes. In addition, we compared nucleosome spacing at gene-body regions between active and silent genes, but we found no significant differences ( Supplementary Fig. 4 ).
Genome-wide impact of Foxa2 on nucleosome positioning
Foxa1 and Foxa2 have similar DNA binding domains (>95% amino acid identity) and share similar DNA target sequences [17] [18] [19] . We mapped all Foxa2 binding sites in the mouse liver by ChIP-Seq and identified 8,102 Foxa2 binding regions, corresponding to 4,435 genes. We found that Foxa2 bound to both nucleosome-free and nucleosomeoccupied DNA (two examples are shown in Fig. 3a) . From the analysis of nucleosome occupancy at all Foxa2 binding sites, Foxa2 showed a limited preference for nucleosome-free regions (Fig. 3b) . The majority of nucleosome-free regions surrounding Foxa2 binding sites were ~200 bp in width ( Fig. 2g) . Among all Foxa2 binding sites, at least half were nucleosome free, whereas the rest showed evidence for cooccupancy with nucleosomes ( Supplementary Fig. 5 ). The two sets of binding sites produced nearly identical positional weight matrices, indicating that no specific sequence directs Foxa2 to bind to nucleosomal DNA (Fig. 3c) .
To confirm the interaction between Foxa2 and nucleosomes, we conducted sequential ChIPs with anti-Foxa2 and anti-histone H3 antibodies in both orders. The nucleosome-coupled Foxa2 targets were indeed occupied by nucleosomes, in contrast to the Foxa2 sites in nucleosome-free regions (Fig. 3d) . In addition, we found Foxa2 binding sites even at large distances from transcriptional start sites (Fig. 3e) . There was no difference in the distribution of nucleosome-bound and -free Foxa2 binding sites, with the exception of the regions from transcriptional start sites to 2 kilobases (kb) upstream, which were enriched for nucleosome-free Foxa2 binding events ( Fig. 3e) . Finally, we investigated the correlation between nucleosome occupancy at Foxa2 binding sites and gene expression of the closest gene ( Supplementary Fig. 6 ). Twenty percent of the genes analyzed were associated with both nucleosome-free and -occupied Foxa2 binding sites. There was no difference in the level of gene expression between those genes that were only associated with nucleosome-free Foxa2 binding sites and those associated with only nucleosome-bound Foxa2 sites ( Supplementary Fig. 6 ). These data indicate that nucleosome occupancy at Foxa2 binding sites does not correlate with gene-expression levels in the liver.
Others have reported recently that the methylation status of CpG sites near the Foxa binding site of the Alb1 enhancer plays an essential role in the differentiation of embryonic stem cells to endoderm in vitro 20 . Considering the recent finding that nucleosomal DNA is enriched with methylated CpGs 21 , we expected that the CpG sites in the Alb1 enhancer would be highly methylated and occupied by nucleosomes. Indeed, the classical Alb1 enhancer was bound by both Foxa2 and nucleosomes in the liver (Fig. 3a, upper panel) .
This finding seemed to be inconsistent with our data showing that intergenic CpG islands were nucleosome depleted ( Fig. 2f) , so we investigated the relationship between CpG islands and Foxa2 binding sites on the genome-wide level. Unexpectedly, the genomewide distribution of CpG islands surrounding Foxa2 binding sites showed that CpG islands were depleted at Foxa2 binding sites but relatively enriched nearby, either upstream or downstream of the Foxa2 binding site ( Fig. 4a, Supplementary Fig. 7) . However, Foxa2 binding sites with nearby CpG islands only accounted for ~8% (720 sites) of all Foxa2 sites. This particular group of Foxa2 binding sites mostly resides within 2 kb of transcriptional start sites, in contrast to the much broader distribution of all Foxa2 binding sites ( Figs. 4b  and 3e) ; thus, CpG islands form boundaries near a subset of Foxa2 binding sites. 
Nucleosome position independent of Foxa1 and Foxa2 in adult liver
To investigate the impact of the Foxa proteins on nucleosome positioning in the adult liver, we conducted loss-of-function analysis for both the Foxa1 and Foxa2 genes using Cre-loxP technology 11 , in which the Foxa1 and Foxa2 proteins were specifically ablated in the liver at about day 14.5 of gestation. By means of gene-expression profiling, we found that 658 genes showed at least a two-fold difference in mRNA expression level between mutant and control liver. By determining the intersection between the set of differentially expressed genes and our Foxa2 target list from ChIP-Seq, we found 197 of the differentially expressed genes to be directly regulated by Foxa2 (Fig. 4c) . The 369 Foxa2 binding sites regulating these 197 genes were localized mostly at enhancer regions at least 2 kb away from transcriptional start sites (Fig. 4d) . In addition, there was no clear difference in the nucleosome occupancy pattern at Foxa2 binding of genes whose expression was altered in Foxa1-and Foxa2-deficient liver, compared to those whose expression was not altered (data not shown).
Next, we asked whether nucleosomes are able to reoccupy the nucleosome-free regions at Foxa binding sites when Foxa1 and Foxa2 are deleted in the liver. We found no change in nucleosome occupancy in Foxa1 and Foxa2 mutant liver for 16 randomly chosen genomic loci, regardless of whether they were nucleosome free or nucleosome occupied in normal liver (Fig. 4e) . We could not analyze mice deficient for Foxa1, Foxa2 and Foxa3, as these mice are not viable. As an alternative, we analyzed cells and tissues without any Foxa expression, including undifferentiated mouse embryonic stem cells and mouse heart. Several Foxa2 binding sites that were nucleosome free in the liver were indeed occupied by nucleosomes in embryonic stem cells and heart (five out of eight regions tested), suggesting that Foxa proteins might be required to open chromatin at these regions (Fig. 4e) . However, three of the nucleosome-free Foxa2 binding sites in the liver were still nucleosome free even in heart and embryonic stem cells (Fig. 4e) . Conversely, eight Foxa2 binding sites that were nucleosome bound in the liver were completely nucleosome free in embryonic stem cells and heart (Fig. 4e) . None of the regions tested were occupied by nucleosomes in all four tissues or cell types. These data suggest that nucleosome positioning is independent of Foxa1 and Foxa2 in the adult mouse liver but do not preclude the possibility that Foxa factors reposition nucleosomes during embryonic development, or that Foxa3, Foxd3 and other Fox factors may bind to Foxa1 and Foxa2 binding sites when Foxa1 and Foxa2 are absent. However, we previously showed that no liver forms when both Foxa1 and Foxa2 are ablated during gastrulation 10 , suggesting that Foxa3 is unable to compensate for the loss of Foxa1 and Foxa2. Foxd3 expression is high during early development but declines in adulthood and is not detectable in the adult liver 22 .
Next, we investigated whether lack of Foxa1 and Foxa2 leads to changes in chromatin structure. Hp1 and trimethylated histone H3 lysine 9 (H3K9me3) are genomic markers of heterochromatin 23, 24 . Following ChIP-Seq, we plotted the Hp1 distribution surrounding all Foxa2 binding sites and H3K9me3 sites. Although H3K9me3 sites r e s o u r c e were highly enriched for Hp1 binding, Foxa2 binding sites were Hp1free, indicating that Foxa2 bound at euchromatic regions (Fig. 4f) . Unexpectedly, this was also true for these sites in Foxa1-and Foxa2deficient livers (Fig. 4g) . CBP and p300 mark genomic regions under the transition from heterochromatin to euchromatin, and also mark enhancer regions 25, 26 . We also investigated genome-wide locations of CBP and p300 in both control and mutant livers by ChIP-Seq. Genome-wide distribution analysis showed that most (>90%) of CBP and p300 binding sites were localized at putative enhancer regions (>5 kb from the transcription starting site) in both control and mutant livers (Supplementary Fig. 8 ). Just as for Hp1, CBP and p300 binding was also absent from most Foxa2 binding sites in both control and mutant livers (Fig. 4f,g) ; thus, Foxa1 and Foxa2 are dispensable for the maintenance of chromatin structure in the liver, at least at the regions surrounding Foxa2 binding sites.
Although overall genome-wide Foxa2 binding did not correlate with reduced nucleosome occupancy and altered gene expression, we discovered that a subset of Foxa2 binding sites near promoters were bound by CpG islands. Our study is the first to report genome-wide mapping of nucleosome positions in the mouse genome. Mapping of nucleosome positions in an organ rather than cultured cell lines is challenging because of tissue heterogeneity. Nevertheless, we were able to identify distinct nucleosome positions in the liver because hepatocytes account for ~80% of liver nuclei. Our findings further indicate that nucleosome positions are nearly uniform in hepatocytes despite the zonation of the liver into periportal and pericentral regions. Our high-resolution maps of nucleosomes revealed nucleosome depletion at transcriptional start sites of housekeeping genes, highly expressed genes and some silent genes, and also at CpG islands.
DISCUSSION
Combining genome-wide mapping of Foxa2 occupancy and gene ablation analysis, we found that Foxa1 and Foxa2 are dispensable for maintaining nucleosome positions and chromatin structure in the adult mouse liver. Our findings and prior in vitro studies would suggest that Foxa proteins act as pioneer factors in the initial reprogramming of chromatin during endoderm development when other transcription factors are not abundant. Although prior genetic data support the notion of the Foxa factors as pioneer factors 10 , other interpretations are also possible: for example, the Foxa proteins could regulate a set of essential molecules required for liver specification but not act by globally modifying chromatin. Nevertheless, our current findings explain why hepatocyte differentiation was shown to be relatively unaffected when Foxa1 and Foxa2 were ablated in the liver during late gestation 11 .
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
ONLINE METHODS
Sequencing and analysis of nucleosomal DNA. Nuclei were isolated from control (Foxa1 loxP/loxP and Foxa2 loxP/loxP ) and mutant (Foxa1 loxP/loxP , Foxa2 loxP/loxP and AlfpCre) mouse liver 11 as well as mouse embryonic stem cells and mouse heart by gradient ultracentrifugation 27 . Native chromatin without cross-linking was released from nuclei by incubation in the buffer containing 0.1 N CaCl 2 , then digested with MNase (Roche) for 15 min (partial digestion) and 30 min (full digestion) 28 . Mononucleosomal DNA was collected and pooled from both partial and full digestion of four mouse livers (Supplementary Fig. 1) . Mononucleosomal and undigested genomic DNA were purified with the Qiagen PCR purification kit after digestion with protease K (Qiagen). For DNA sequencing, nucleosomal DNA was further modified following the Illumina sequencing protocol and sequenced with an Illumina Genome Analyzer.
We obtained approximately 124 million reads of 36 nucleotides (nt) that uniquely align to the mouse genome (mm8, University of California, Santa Cruz (UCSC) genome database). We then extended 36-nt reads to 120 bp according to the average size of nucleosomal DNA fragments. The stack-height profiles of nucleosome DNA were determined by the number of times a given nucleotide was included in one of our sequencing reads and loaded into the TessLA genome browser for visualization (unpublished software; details available from the authors on request). Nucleosome positions were defined as genomic regions containing at least four extended reads, based on the average reads at each sequencing locus with a 20% false discovery rate (FDR). The rest of the regions were considered to be nucleosome free. We used 20% FDR because of the heterogeneity of liver cells, ~80% of which are hepatocytes; thus, each position having three or less reads was considered to be from nonhepatocytes. Once a nucleosome position was identified from four or more extended nucleosomal reads, only one nucleosome score was given, regardless of the number of reads at this position. The distribution of nucleosomes surrounding transcriptional start sites, CpG islands or Foxa2 binding sites was plotted from the average nucleosome scores of these sites. Transcriptional start sites and CpG islands were collected from the UCSC genome database. Intergenic CpG islands were defined from those located more than 5 kb distant to the nearest gene. For qPCR, undigested genomic DNA was used as input control. Nucleosome occupancy was calculated using the equation 2 −(Ct nucleosome −Ct input ) , where Ct = threshold cycle. The data shown in Figure 4c represent the analysis from each set of three primer pairs (Supplementary Fig. 9 ).
Chromatin immunoprecipitation coupled Solexa sequencing (ChIP-Seq)
and ChIP assays. ChIP assays were done as described previously 29 . For ChIP-Seq, after cross-linking, chromatin was sonicated to reduce the size of DNA to ~100-1,000 bp, which was further modified for Illumina sequencing as described above. A total of 21, 6 (6), 27 (20) , 15 (29) and 21 (13) million uniquely aligned reads were obtained for Foxa2, HP1, CBP, p300 and H3K9me3 ChIP-Seq, respectively (numbers in parentheses are from mutant liver). ChIP-Seq binding regions were identified with the input-directed algorithm GLITR 30 . Positional weight matrices of Foxa2 binding sites were generated using the WebLogo program 31 . For sequential ChIPs (sChIP), ChIP assays were done with MNase-digested chromatin. The order of sChIP was sChIP-1 (anti-Foxa2 → anti-histone H3) and sChIP-2 (anti-histone H3 → anti-Foxa2). The antibodies used were anti-Foxa2 antibody (J.A. Whitsett, Cincinnati Children's Hospital Medical Center), anti-histone H3 antibody (Abcam), anti-Hp1 antibody (Abcam), anti-CBP antibody (Abcam), anti-p300 antibody (Millipore) and anti-H3K9me3 antibody (Abcam, Millipore). For ChIP assays, input and precipitated DNA fragments were subjected to quantitative real-time PCR with primer sets for putative binding sites of Foxa2 and histone H3. Enrichment of the targets was calculated using the 28S rRNA locus as a reference and is shown relative to the input chromatin.
Gene expression microarray. Liver RNA was isolated from four control and four Foxa1 and Foxa2 mutant mice at 3 months of age. RNA was reverse transcribed and labeled as described previously 32 . Fluorescence-labeled cDNAs were hybridized to the Whole Mouse Genome Oligo Microarray (Agilent). This microarray chip represents over 41,000 mouse gene transcripts. Genes showing a change over two-fold between mutants and controls and an FDR of less than 10%, as calculated by SAM (significance analysis of microarray) analysis 33 , were selected.
